Aisa Pharma
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
33 Brimmer St Apt C, Boston, Massachuset...Phone Number
(617) 584-7292Website
www.aisapharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Aisa Pharma
Aisa Pharma, Inc. is a late-stage clinical development company focused on creating innovative treatments for patients suffering from severe autoimmune and vascular diseases, particularly those with Systemic Sclerosis and Raynaud's disease. Their primary product, Profervia®, aims to address the pressing medical needs of individuals affected by Raynaud's phenomenon. The company boasts a team with over 100 years of experience in drug development and a strong advisory board of biopharma experts. Aisa Pharma is headquartered in Boston, with additional offices in California and Australia.Explore more
Aisa Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aisa Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Aisa Pharma
Earning: See what the market has to say on Aisa Pharma recently announced quarterly report
Product Launch: Get notified when Aisa Pharma launches new products
Click to see if Aisa Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Aisa Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Aisa Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Aisa Pharma has new funding data
Check out if Aisa Pharma is spiking on competitors!
Recommended Actions
Find VP level buyers at Aisa Pharma
Find 2 more new buyers
Compare Similar Companies to Aisa Pharma
Compare insights from companies similar to Aisa Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aisa Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aisa Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aisa Pharma.
Aisa Pharma Tech Stack
A closer look at the technologies used by Aisa Pharma
See more technologies
Aisa Pharma News & Media
AISA Pharma Announces Completion of Enrollment in Phase 2 RECONNOITER Trial of AISA-021 in Systemic Sclerosis-Related Raynaud's Phenomenon
Results from Phase 2 RECONNOITER trial accepted as oral presentation at World Systemic Sclerosis Conference in Athens, Greece March 5-7, 2026 Dr. Norman Stockbridge, Former FDA Division Director, to consult for AISA on Phase 3 design and regulatory strategy BOSTON, Dec. 2, 2025...AISA Pharma Receives FDA Orphan Drug Designation for AISA-021 for Treatment of Systemic Sclerosis
Company also provides updates on its Phase 2 RECONNOITER Study in Raynaud's Phenomenon and Systemic Sclerosis and other corporate activities BOSTON, Sept. 9, 2024 /PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company announced that the U.S. Food and Drug...AISA Pharma Announces Start of Phase 2b Profervia® Study for Raynaud's Phenomenon in Systemic Sclerosis (SSc)
Phase 2 Data at EULAR Suggested Profervia® Treatment Might Influence Systemic Sclerosis (SSc) Disease Severity BOSTON, June 21, 2023 /PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company today announced initiation of Part 2 of the RECONNOITER Phase 2 study,...AISA Pharma Announces NIH-NINDS Award to investigate Profervia® as a non-opioid analgesic for acute and chronic pain
BOSTON, April 3, 2023 /PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, announces that the National Institute of Neurological Disorders and Stroke (NINDS)- National Institutes of Health (NIH) have awarded the Preclinical Screening Pain Platform (PSPP)...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aisa Pharma
Sign Up For FreeTo access detailed company insights
Aisa Pharma, Inc. is a late-stage clinical development company focused on creating innovative treatments for patients suffering from severe autoimmune and vascular diseases, particularly those with Systemic Sclerosis and Raynaud's disease. Their primary product, Profervia®, aims to address the pressing medical needs of individuals affected by Rayna... Read More
